White Paper
EU GMP Annex 1 and Parenteral Packaging: A Quality by Design Approach to Sterile Manufacturing
What EU GMP Annex 1 means for parenteral packaging manufacturers and how a Quality by Design approach to sterile manufacturing keeps pharmaceutical companies ahead of compliance requirements.
Status
Published
Format
White Paper
Language
English
Access
Registration Required
Resource Overview
About this White Paper
The 2023 enforcement of EU GMP Annex 1 represents the most significant update to sterile manufacturing guidelines in decades, introducing a mandatory Contamination Control Strategy (CCS) framework that references primary packaging suppliers directly and by name more than 50 times throughout the document. This report by Datwyler explains the structure and intent of EU GMP and Annex 1, the role of the EMA in enforcing compliance, and what the new requirements mean in practice for parenteral packaging components — including container closure integrity (CCI) validation, endotoxin reduction (Log 3 minimum), sterilization validation, and the adoption of advanced technologies such as Restricted Access Barrier Systems (RABS) and isolators.
The paper applies a Quality by Design (QbD) lens to elastomeric component development, examining three critical design dimensions: component geometry and CCI fit, elastomer compound selection and extractables/leachables profile, and siliconization/coating decisions affecting machinability and drug compatibility. It also covers the implications of Annex 1 for different packaging supply formats — Ready-for-Sterilization (RFS), Ready-to-Use (RTU), and RTP variants — and demonstrates how Datwyler's FirstLine® manufacturing environment, with its automated production cells, full cleanroom zoning, validated washing processes, and fluoropolymer spray coating technology, is purpose-designed to meet and exceed Annex 1 requirements while supporting pharmaceutical customers' global supply chain compliance.
Access This Resource
Download the White Paper
Continue to access the full resource.
Access the White Paper
Quick access in under 30 seconds.
